BlackRock’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.5M | Buy |
|
|||||
|
2025
Q1 | $39M | Sell |
|
|||||
|
2024
Q4 | $42.3M | Sell |
|
|||||
|
2024
Q3 | $92.8M | Buy |
|
|||||
|
2024
Q2 | $101M | Buy |
|
|||||
|
2024
Q1 | $160M | Sell |
|
|||||
|
2023
Q4 | $147M | Buy |
|
|||||
|
2023
Q3 | $132M | Sell |
|
|||||
|
2023
Q2 | $165M | Buy |
|
|||||
|
2023
Q1 | $152M | Buy |
|
|||||
|
2022
Q4 | $152M | Buy |
|
|||||
|
2022
Q3 | $173M | Sell |
|
|||||
|
2022
Q2 | $164M | Buy |
|
|||||
|
2022
Q1 | $219M | Buy |
|
|||||
|
2021
Q4 | $215M | Buy |
|
|||||
|
2021
Q3 | $267M | Buy |
|
|||||
|
2021
Q2 | $241M | Sell |
|
|||||
|
2021
Q1 | $215M | Buy |
|
|||||
|
2020
Q4 | $246M | Sell |
|
|||||
|
2020
Q3 | $156M | Buy |
|
|||||
|
2020
Q2 | $204M | Buy |
|
|||||
|
2020
Q1 | $163M | Sell |
|
|||||
|
2019
Q4 | $214M | Buy |
|
|||||
|
2019
Q3 | $183M | Buy |
|
|||||
|
2019
Q2 | $259M | Buy |
|
|||||
|
2019
Q1 | $280M | Buy |
|
|||||
|
2018
Q4 | $202M | Buy |
|
|||||
|
2018
Q3 | $357M | Buy |
|
|||||
|
2018
Q2 | $303M | Buy |
|
|||||
|
2018
Q1 | $66.3M | Sell |
|
|||||
|
2017
Q4 | $76M | Sell |
|
|||||
|
2017
Q3 | $99M | Buy |
|
|||||
|
2017
Q2 | $56.1M | Buy |
|
|||||
|
2017
Q1 | $45.9M | Buy |
|
|||||
|
2016
Q4 | $94K | Sell |
|
|||||
|
2016
Q3 | $93K | Buy |
|
|||||
|
2016
Q2 | $39K | Buy |
|
|||||
|
2016
Q1 | $1K | Buy |
|
|||||
|
2015
Q4 | $2K | Buy |
|